Texas Capital Bancshares Inc Bristol Myers Squibb CO Transaction History

Texas Capital Bancshares Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $636 - $712	11 Added 0.31%	3,607 $209,000
Q2 2023 Aug 09, 2023	SELL	$63.71 - $70.74 $7,454 - $8,276	-117 Reduced 3.15%	3,596 $229,000
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $4,402 - $4,993	67 Added 1.84%	3,713 $257,000
Q2 2022 Aug 04, 2022	BUY	$72.62 - $79.98 $264,772 - $291,607	3,646 New	3,646 $281,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Texas Capital Bancshares Inc, based on Form 13F filings with the SEC.

Stay updated on Texas Capital Bancshares Inc with notifications on news.